Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China Using Healthcare Reforms To Upgrade National Medical Device Industry

This article was originally published in PharmAsia News

Executive Summary

Sang Guowei, Vice Chairman of the Standing Committee of the National People's Congress, recently headed a delegation to Jiangsu, Shanghai and Chongqing to conduct studies on implementing healthcare reforms in grassroots healthcare institutions. One focus was facility upgrading and reform pilots in public hospitals. The studies show that there is a widespread shortage or lack of timely servicing of equipment in grassroots healthcare institutions, and that more than 60 percent of village hospitals lack basic medical facilities. Sang pointed out that the country should leverage the healthcare reforms to raise medical device deployment standards for such institutions, focus on modernization of mid- and low-end medical devices, and develop innovative medical devices. (Click here for more - Chinese Language)
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC071451

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel